• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrazines Pyridopyrazines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrazines

Recent Advances in the Study of 2-Chloro-pyrido[2,3-b]pyrazine Dihydrochloride (CAS: 1187931-12-9)

2-Chloro-pyrido[2,3-b]pyrazine dihydrochloride (CAS: 1187931-12-9) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have focused on its role as a key intermediate in the synthesis of novel therapeutic agents, particularly in the areas of oncology and infectious diseases. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential clinical applications.

One of the most notable advancements in the study of 2-Chloro-pyrido[2,3-b]pyrazine dihydrochloride is its incorporation into the design of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with cancer and other diseases. Researchers have demonstrated that derivatives of this compound exhibit potent inhibitory activity against specific kinases, such as EGFR and BRAF, which are frequently mutated in various cancers. These findings suggest that 2-Chloro-pyrido[2,3-b]pyrazine dihydrochloride could serve as a valuable scaffold for the development of targeted cancer therapies.

In addition to its applications in oncology, recent studies have explored the antimicrobial properties of 2-Chloro-pyrido[2,3-b]pyrazine dihydrochloride. Preliminary in vitro assays have shown that this compound and its derivatives exhibit activity against a range of bacterial and fungal pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans. These results highlight the potential of this compound as a starting point for the development of new antimicrobial agents, particularly in light of the growing threat of antibiotic resistance.

The synthesis and optimization of 2-Chloro-pyrido[2,3-b]pyrazine dihydrochloride derivatives have also been a focus of recent research. Advances in synthetic chemistry have enabled the efficient production of diverse analogs, allowing for structure-activity relationship (SAR) studies. These studies have provided valuable insights into the molecular features that contribute to the compound's biological activity, paving the way for the design of more potent and selective drug candidates.

Despite these promising developments, challenges remain in the translation of 2-Chloro-pyrido[2,3-b]pyrazine dihydrochloride-based compounds into clinical applications. Issues such as bioavailability, toxicity, and pharmacokinetic properties need to be addressed through further preclinical studies. Nonetheless, the compound's versatility and demonstrated biological activities make it a compelling subject for ongoing research in the chemical biology and pharmaceutical sciences.

In conclusion, 2-Chloro-pyrido[2,3-b]pyrazine dihydrochloride (CAS: 1187931-12-9) represents a promising scaffold for the development of novel therapeutic agents. Recent studies have underscored its potential in oncology and antimicrobial therapy, while advances in synthetic chemistry have facilitated the exploration of its SAR. Future research should focus on addressing the remaining challenges to unlock the full therapeutic potential of this compound.

• 889447-19-2(2-Chloro-5H-pyrrolo[2,3-B]pyrazine)
• 240815-50-3(Imidazo[1,5-a]pyrido[3,2-e]pyrazine,6-chloro-)
• 104149-54-4(6-chloro-Pyrido[2,3-e]pyrrolo[1,2-a]pyrazine)
• 70838-55-0(2-Chloropyrido2,3-Bpyrazine)
• 68236-03-3(6-Chloropyrido[2,3-b]pyrazine)
• 1071588-27-6(5-chloro-3H-Imidazo[4,5-b]pyridine hydrochloride)
• 155535-23-2(3-Chloropyrido2,3-bpyrazine)
• 25710-18-3(2,3-Dichloropyrido[2,3-b]pyrazine)
• 52090-89-8(5-Chloro-3H-imidazo[4,5-b]pyridine)
• 1111638-10-8(3-Chloro-5H-pyrrolo[2,3-b]pyrazine)